Letícia Rangel
Leticia B. A. Rangel, Pharm.D., Ph.D., is a Full Professor of the Department of Pharmaceutical Sciences, as well as a member of the Biotechnology Program/RENORBIO and the Biochemistry and Pharmacology Program at the Federal University of Espirito Santo (UFES). As the Head of the Laboratory of Cellular and Molecular Biology of Human Cancer, she coordinates projects on ovarian and breast cancers, with emphasis on the cellular and molecular mechanisms of these diseases, the development of biotechnology products and processes, and the discovery of new anticancer molecules. Her scientific network includes the Institute of Biophysics Carlos Chagas Filho (Federal University of Rio de Janeiro), the Division of Clinical Research of the Brazilian National Cancer Institute, The Department of Molecular Medicine, University of Texas at San Antonio (USA), the H. Lee Moffitt Cancer Center (USA), and the Department of Pathology at the John Hopkins University (USA), as well as the private sector. Aside from papers published in international journals, and ongoing patent negotiations, she has been awarded by the Brazilian government in recognition to her contribution in cancer research.